Sclerotherapy now the number two most performed cosmetic surgical procedure thanks to men

NewsGuard 100/100 Score

The American Academy of Cosmetic Surgery (AACS) is pleased to announce the results of its 2007 Procedural Data.

This information is collected by polling the Academy's U.S.-based members.

Findings conclude that sclerotherapy, the standard treatment for spider and varicose veins, is now the number two most performed cosmetic surgical procedure, due in large part to men. Sclerotherapy has seen a 226.3% increase in males over the past five years. A drastic comparison to the 3.5% increase in females since 2002.

On the opposite end, males have strayed away from hair transplants. Cost is likely to be a cause of this decline. Over five years, the price of hair transplants increased by $1,296, while sclerotherapy decreased by $103.

“Cosmetic surgeons have experienced a boost of males wishing to receive sclerotherapy,” says Dr. Steven Hopping, MD, President of the AACS. “Now, there are notably fewer stigmas associated with men receiving this procedure.”

The top three most performed cosmetic surgical procedures in 2007 include: liposuction, sclerotherapy and blepharoplasty; while the most popular non-surgical cosmetic procedures were Botox® injections, microdermabrasion and chemical peels.

The 2007 Procedural Data is based on a survey of U.S.-based AACS members completed in December 2007. The entire report, conducted by RH Research, is available by contacting the Academy.

http://www.cosmeticsurgery.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hearing loss linked to accelerated Alzheimer's progression via GDF1 pathway